High GLUT1 membrane expression and low PSMA membrane expression in Ductal Adenocarcinoma and Intraductal Carcinoma of the prostate
Prostate Cancer and Prostatic Diseases, Published online: 25 November 2023; doi:10.1038/s41391-023-00759-yHigh GLUT1 membrane expression and low PSMA membrane expression in Ductal Adenocarcinoma and Intraductal Carcinoma of the prostate (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - November 25, 2023 Category: Urology & Nephrology Authors: Xingming Wang Li Zhou Lin Qi Ye Zhang Hongling Yin Yu Gan Xiaomei Gao Yi Cai Source Type: research

Comparison of procedural anxiety and pain associated with conventional transrectal ultrasound prostate biopsy to magnetic resonance imaging-ultrasound fusion-guided biopsy: a prospective cohort trial
Prostate Cancer and Prostatic Diseases, Published online: 25 November 2023; doi:10.1038/s41391-023-00760-5Comparison of procedural anxiety and pain associated with conventional transrectal ultrasound prostate biopsy to magnetic resonance imaging-ultrasound fusion-guided biopsy: a prospective cohort trial (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - November 25, 2023 Category: Urology & Nephrology Authors: Sriram Deivasigamani Eric S. Adams Srinath Kotamarti Mahdi Mottaghi Terek Taha Ali Aminsharifi Zoe Michael Denis Seguier Thomas J. Polascik Source Type: research

Is there a role for radical prostatectomy in the management of oligometastatic prostate cancer? A systematic review
Prostate Cancer and Prostatic Diseases, Published online: 20 November 2023; doi:10.1038/s41391-023-00752-5Is there a role for radical prostatectomy in the management of oligometastatic prostate cancer? A systematic review (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - November 20, 2023 Category: Urology & Nephrology Authors: A. Saouli A. Touzani A. Martini J. B. Beauval H. Dergamoun I. Ziouziou N. Deffar G. Ploussard A. Ouzzane Source Type: research

Correction: Hormonal treatment for newly diagnosed metastatic prostate cancer: a population-based study from the California cancer registry
Prostate Cancer and Prostatic Diseases, Published online: 14 November 2023; doi:10.1038/s41391-023-00749-0Correction: Hormonal treatment for newly diagnosed metastatic prostate cancer: a population-based study from the California cancer registry (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - November 14, 2023 Category: Urology & Nephrology Authors: David J. Benjamin Anshu Shrestha Dimitra Fellman Rosemary D. Cress Mark P. Lythgoe Arash Rezazadeh Kalebasty Source Type: research

ChatGPT in prostate cancer: myth or reality?
Prostate Cancer and Prostatic Diseases, Published online: 10 November 2023; doi:10.1038/s41391-023-00750-7ChatGPT in prostate cancer: myth or reality? (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - November 10, 2023 Category: Urology & Nephrology Authors: Riccardo Lombardo Antonio Cicione Giuseppe Santoro Cosimo De Nunzio Source Type: research

Early PSA decline after starting second-generation hormone therapy in the post-docetaxel setting predicts cancer-specific survival in metastatic castrate-resistant prostate cancer
Prostate Cancer and Prostatic Diseases, Published online: 07 November 2023; doi:10.1038/s41391-023-00751-6Early PSA decline after starting second-generation hormone therapy in the post-docetaxel setting predicts cancer-specific survival in metastatic castrate-resistant prostate cancer (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - November 7, 2023 Category: Urology & Nephrology Authors: Mohamed E. Ahmed Matthew S. Lee Ahmed M. Mahmoud Vidhu B. Joshi Ajay Gopalakrishna Raevti Bole Rimki Haloi A. Tuba Kendi Michael S. Bold Alan H. Bryce Robert Jeffrey Karnes Eugene D. Kwon Daniel S. Childs Jack R. Andrews Source Type: research

External validation of nomograms including MRI features for the prediction of side-specific extraprostatic extension
Prostate Cancer and Prostatic Diseases, Published online: 06 November 2023; doi:10.1038/s41391-023-00738-3External validation of nomograms including MRI features for the prediction of side-specific extraprostatic extension (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - November 6, 2023 Category: Urology & Nephrology Authors: J. G. Heetman E. J. R. J. van der Hoeven P. Rajwa F. Zattoni C. Kesch S. Shariat F. Dal Moro G. Novara G. La Bombara F. Sattin N. von Ostau N. P ötsch P. A. T. Baltzer L. Wever J. P. A. Van Basten H. H. E. Van Melick R. C. N. Van den Bergh G. Gandaglia T Source Type: research

Editorial: new horizons in robotic platforms
Prostate Cancer and Prostatic Diseases, Published online: 06 November 2023; doi:10.1038/s41391-023-00753-4Editorial: new horizons in robotic platforms (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - November 6, 2023 Category: Urology & Nephrology Authors: Riccardo Lombardo Matteo Romagnoli Cosimo De Nunzio Simone Albisinni Source Type: research

Digital informed consent for urological surgery - randomized controlled study comparing multimedia-supported vs. traditional paper-based informed consent concerning satisfaction, anxiety, information gain and time efficiency
Prostate Cancer and Prostatic Diseases, Published online: 04 November 2023; doi:10.1038/s41391-023-00737-4Digital informed consent for urological surgery - randomized controlled study comparing multimedia-supported vs. traditional paper-based informed consent concerning satisfaction, anxiety, information gain and time efficiency (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - November 4, 2023 Category: Urology & Nephrology Authors: Maximilian Haack Nikita D. Fischer Lisa Frey Peter Sparwasser Robert Dotzauer Gregor Duwe Axel Haferkamp Hendrik Borgmann Source Type: research

Quality of information and appropriateness of ChatGPT outputs for urology patients
Prostate Cancer and Prostatic Diseases, Published online: 03 November 2023; doi:10.1038/s41391-023-00754-3Quality of information and appropriateness of ChatGPT outputs for urology patients (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - November 3, 2023 Category: Urology & Nephrology Authors: Andrea Cocci Marta Pezzoli Mattia Lo Re Giorgio Ivan Russo Maria Giovanna Asmundo Mikkel Fode Giovanni Cacciamani Sebastiano Cimino Andrea Minervini Emil Durukan Source Type: research

Retreatment rates and postprocedural complications are higher than expected after BPH surgeries: a US healthcare claims and utilization study
Prostate Cancer and Prostatic Diseases, Published online: 26 October 2023; doi:10.1038/s41391-023-00741-8Retreatment rates and postprocedural complications are higher than expected after BPH surgeries: a US healthcare claims and utilization study (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - October 26, 2023 Category: Urology & Nephrology Authors: Steve Kaplan Ronald P. Kaufman Jr Thomas Mueller Dean Elterman Bilal Chughtai Daniel Rukstalis Henry Woo Claus Roehrborn Source Type: research

Safety and tolerability of long-term treatment with darolutamide in patients with metastatic castration-resistant prostate cancer
Prostate Cancer and Prostatic Diseases, Published online: 26 October 2023; doi:10.1038/s41391-023-00740-9Safety and tolerability of long-term treatment with darolutamide in patients with metastatic castration-resistant prostate cancer (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - October 26, 2023 Category: Urology & Nephrology Authors: Robert Hugh Jones Karim Fizazi Nicholas D. James Teuvo L. Tammela Nobuaki Matsubara Frank Priou Philippe Beuzeboc Thierry Lesimple Petri Bono Vesa Kataja Jorge A. Garcia Andrew Protheroe Neal Shore John Aspegren Heikki Joensuu Iris Kuss Sabine Fiala-Buski Source Type: research

Shifting the paradigm in high-risk prostate cancer: how good is TNM alone?
Prostate Cancer and Prostatic Diseases, Published online: 26 October 2023; doi:10.1038/s41391-023-00748-1Shifting the paradigm in high-risk prostate cancer: how good is TNM alone? (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - October 26, 2023 Category: Urology & Nephrology Authors: Fouad Aoun Elie Helou Simone Albisinni Source Type: research

Impact of peritoneal reconfiguration on lymphocele formation after robot-assisted radical prostatectomy with pelvic lymph node dissection: a systematic review and meta-analysis of randomized controlled trials
Prostate Cancer and Prostatic Diseases, Published online: 24 October 2023; doi:10.1038/s41391-023-00744-5Impact of peritoneal reconfiguration on lymphocele formation after robot-assisted radical prostatectomy with pelvic lymph node dissection: a systematic review and meta-analysis of randomized controlled trials (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - October 24, 2023 Category: Urology & Nephrology Authors: Francesco Ditonno Celeste Manfredi Antonio Franco Alessandro Veccia Fabrizio Dal Moro Cosimo De Nunzio Marco De Sio Alessandro Antonelli Riccardo Autorino Source Type: research

Characteristics of incidental prostate cancer in the United States
Prostate Cancer and Prostatic Diseases, Published online: 23 October 2023; doi:10.1038/s41391-023-00742-7Characteristics of incidental prostate cancer in the United States (Source: Prostate Cancer and Prostatic Diseases)
Source: Prostate Cancer and Prostatic Diseases - October 23, 2023 Category: Urology & Nephrology Authors: Lukas Scheipner Reha-Baris Incesu Simone Morra Andrea Baudo Anis Assad Letizia Maria Ippolita Jannello Carolin Siech Mario de Angelis Francesco Barletta Zhe Tian Fred Saad Shahrokh F. Shariat Alberto Briganti Felix K. H. Chun Derya Tilki Nicola Longo Luca Source Type: research